BICO Group AB (BICO) Stock Overview

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioautomation segment offers products in precision dispensing, sample preparation, multiplex analysis and assay miniaturization, and diagnostic and medical device manufacturing for life science and diagnostic industries. The Biosciences segment provides user-friendly instruments that enable handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioprinting segment offers products, solutions, and services that proliferation of 3D cell culture and 3D printing of tissues and organs. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.